Eli Lilly | Times Square Investment Journal

Immune to market slump, these four major healthcare stocks are on an expansion kick

by Cailley LaPara | Sep 20, 2022

The economy may be ailing but dominant healthcare stocks have so far resisted infection, and look poised to continue thriving. Pharmacy retailer and insurer CVS (CVS) closed Friday at $102 per share, just about where it began the year. Leading drug manufacturer Eli...

Insulin Price Caps and Tough Litigation Won’t Bury Big Pharma

by Lucy Papachristou | Sep 20, 2022

By Lucy Papachristou Federal legislative overhaul of the healthcare sector is throwing a wrench into Big Pharma’s growth this fall, but companies are expected to weather the storm in a market hungry for new drug therapies. Stocks of insulin producers Eli...